SCHEMBL21717027

SCHEMBL21717027

c1ccc2cc(-c3nc4ccccc4nc3-c3ccc4cc(-n5c6ccc(-n7c8ccccc8c8c9ccccc9ccc87)cc6c6cc7ccccc7cc65)ccc4c3)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.34
MAPK10 P53779 8/20 0.34
MAPK9 P45984 4/20 0.34
MAPK8 P45983 2/20 0.34
HTR2B P41595 1/20 0.33
HTR5A P47898 1/20 0.33
POLB P06746 2/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
HSP90AA1 P07900 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
HTT P42858 1/20 0.32
GRK6 P43250 1/20 0.32
PTGES O14684 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716237 0.97 MAPK10 (0.36) HPGDMAPK10MAPK9MAPK8HTR2B
SCHEMBL21717026 0.96 LMNA (0.34) HPGDMAPK10MAPK9MAPK8POLB
SCHEMBL21716254 0.95 ADORA2A (0.35) HPGDMAPK10MAPK9MAPK8HTR2B
SCHEMBL21716255 0.93 HPGD (0.32) HPGDHTR2BHTR5APOLBKDM4E
SCHEMBL21716424 0.93 TUBB4A (0.32) HPGDMAPK10MAPK9MAPK8HTR2B
SCHEMBL21716806 0.92 HPGD (0.37) HPGDMAPK10MAPK9MAPK8HTR2B
SCHEMBL21717048 0.92 HPGD (0.37) HPGDMAPK10MAPK9MAPK8HTR2B
SCHEMBL21716703 0.92 KDM4E (0.36) HPGDPOLBKDM4ELMNAHSP90AA1
SCHEMBL21716240 0.91 L3MBTL1 (0.36) HPGDPOLBKDM4ELMNAGAA
SCHEMBL21716897 0.90 L3MBTL1 (0.35) KDM4ELMNAHSP90AA1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 HPGD 652/4885MAPK10 1751/4885MAPK9 1041/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 HPGD 652/4885MAPK10 1751/4885MAPK9 1041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.